Abstract
Hepatocyte growth factor (HGF) is a multifunctional growth factor which has pleiotrophic biological effects on epithelial cells such as proliferation, motogenesis, invasiveness and morphogenesis. Peritoneal dissemination is critical for the progression of ovarian cancer, and our study revealed that HGF induces migration and invasion of ovarian cancer cells. We also demonstrated that HGF stimulates autophosphorylation of its receptor, followed by activation of the Ras-MAP (mitogen-activated peptide) kinase cascade. Moreover, infection of ovarian cancer cells with Ras dominant-negative adenovirus reduced the HGF-induced motogenic and invasive activities. Additionally, both MEK and PI3-kinase pathways downstream of Ras were involved in HGF-stimulated ovarian cancer cell invasiveness. © 2000 Cancer Research Campaign
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Boccacino C, Ando M, Tamagnone L, Bardelli A, Michieli P, Battistini C and Comoglio PM (1998) Induction of epithelial tubules by growth factor HGF depends on the STAT pathway. Nature 391: 285–288
Corps AN, Sowter HM and Smith SK (1997) Hepatocyte growth factor stimulates motility, chemotaxis and mitogenesis in ovarian carcinoma cells expressing high levels of c-Met. Int J Cancer 73: 151–155
DiRenzo MF, Olivero M, Katsaros D, Crepaldi T, Gaglis P, Zola P, Sismondi P and Comoglio PM (1994) Overexpression of the Met/HGF receptor in ovarian cancer. Int J Cancer 58: 658–662
Hartmann G, Weidner KM, Schwartz H and Birchmeier W (1994) The motility signal of scatter factor/hepatocute growth factor mediated through the receptor tyrosine kinase Met requires intracellular action of Ras. J Biol Chem 269: 21936–21939
Jeffer M, Rong S, Anver M and VandeWoude GF (1996 a) Autocrine hepatocyte growth favtor/scatter factor-met signaling induces transformation and invasive/metastatic phenotype in C127 cells. Oncogene 13: 853–861
Jeffer M, Rong S and VandeWoude GF (1996 b) Enhanced tumorigenecity and invasion-metastasis by hepatocyte growth factor/scatter factor-met signaling in human cells concomitant with induction of the urokinase proteolysis network. Mol Cel Biol 16: 1115–1125
Kobayashi H, Moniwa N, Gotoh J, Sugimura M and Terao T (1994) Role of activated protein C in facilitating basement membrane invasion by tumor cells. Cancer Res 54: 261–267
Lamszus K, Schmidt NO, Jin L, Laterra J, Zagzag D, Way D, White M, Weinand M, Goldberg ID, Westphal M and Rosen EM (1998) Scatter factor promotes motility of human glioma and neuromicrovascular endotherial cells. Int J Cancer 75: 19–28
Moghul A, Lin L, Beedle A, Kanbour-Shakir A, DeFrances MC, Liu Y and Zarnegar R (1994) Modulation of c-MET proto-oncogene (HGF receptor) mRNA abundance by cytokines and hormones: evidence for rapid decay of 8 kb c-MET transcript. Oncogene 9: 2045–2052
Montesano R, Matsumoto K, Nakamura T and Orci L (1991) Identification of a fibroblast-derived epithelial morphoge as hepatocyte growth factor. Cell 67: 901–908
Nakamura T, Matsumoto K, Kiritoshi A, Tano Y and Nakamura T (1997) Induction of hepatocyte growth factor in fibroblasts by tumor-derived factors affects invasive growth of tumor cells: in vitro analysis of tumor–stromal interactions. Cancer Res 57: 3305–3313
Parker PJ (1995) Intracellular signaling. PI 3-kinase puts GTP on the rac. Curr Biol 5: 577–579
Pelicci G, Giordano S, Zhen Z, Salcini AE, Lanfrancone L, Bardelli A, Panayotou G, Waterfield MD, Ponzetto C, Pelicci PG and Comoglio PM (1995) The motogenic and mitogenic responses to HGF are amplified by the Shc adaptor protein. Oncogene 10: 1631–1638
Ponzetto C, Bardelli A, Zhen Z, Maina F, Zonca PD, Giordano S, Graziani A, Panayotou G and Comoglio PM (1994) A multifunctional docking site mediates signaling and transformation by the hepatocyte growth factor/scatter factor receptor family. Cell 77: 261–271
Potempa S and Ridley AJ (1998) Activation of both MAP kinase and phosphatidylinositide 3-kinase by ras is required for hepatocyte growth factor/scatter factor-induced adherens junction disassembly. Mol Cell Biol 9: 2185–2200
Ridley AJ, Comoglio PM and Hall A (1995) Regulation of scatter factor/hepatocyte growth factor responses by ras, rac, and rho in MDCK cells. Mol Cell Biol 15: 1110–1122
Rosen EM, Nigam SK and Goldberg ID (1994) Scatter factor and the c-Met receptor: a paradigm for mesenchymal/epitherial interaction. J Cell Biol 127: 1783–1787
Stoker M, Gherardi E, Perryman M and Gray J (1987) Scatter factor is a fibroblast-derived modulator of epithelial cell motility. Nature 327: 239–242
Teneriello MG, Ebina M, Linnoila RI, Henry M, Nash JD, Park RC and Bierrer MJ (1993) p53 and Ki-ras gene mutations in epithelial ovarian neoplasms. Cancer Research 53: 3103–3108
Ueno H, Yamamoto H, Ito S, Li JJ and Takeshita A (1997) Adenovirus-mediated transfer of a dominant-negative H-ras suppresses neointimal formation in balloon-injured arteries in vivo. Arterioscler Thromb Vasc Biol 17: 898–904
Webb CP, Aelst LV, Wilger MH and VandeWoude GF (1998) Signaling pathways in ras-mediated tumorigenicity and metastasis. Proc Natl Acad Sci USA 95: 8773–8778
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Ueoka, Y., Kato, K., Kuriaki, Y. et al. Hepatocyte growth factor modulates motility and invasiveness of ovarian carcinomas via Ras-mediated pathway. Br J Cancer 82, 891–899 (2000). https://doi.org/10.1054/bjoc.1999.1016
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1054/bjoc.1999.1016
Keywords
This article is cited by
-
High-grade serous ovarian cancer cell lines exhibit heterogeneous responses to growth factor stimulation
Cancer Cell International (2015)
-
INC280, an orally available small molecule inhibitor of c-MET, reduces migration and adhesion in ovarian cancer cell models
Scientific Reports (2015)
-
Rab17 inhibits the tumourigenic properties of hepatocellular carcinomas via the Erk pathway
Tumor Biology (2015)
-
High-throughput detection of aberrant imprint methylation in the ovarian cancer by the bisulphite PCR-Luminex method
BMC Medical Genomics (2012)
-
Differential effects of cellular fibronectin and plasma fibronectin on ovarian cancer cell adhesion, migration, and invasion
In Vitro Cellular & Developmental Biology - Animal (2003)